MUMBAI, India, Nov. 7 -- Intellectual Property India has published a patent application (202537089754 A) filed by Nxera Pharma Uk Limited, Cambridge, U.K., on Sept. 20, for 'crystalline form of an ep4 antagonist.'
Inventor(s) include Manage, Ajith; and Mohr, Amandine.
The application for the patent was published on Nov. 7, under issue no. 45/2025.
According to the abstract released by the Intellectual Property India: "This invention relates to a crystalline form of the compound of Formula (1) (1) (1). The invention also relates to compositions and pharmaceutical compositions comprising the crystalline form, to medical uses of the crystalline form, and methods of preparing the crystalline form."
The patent application was internationally...